Matthew Hamilton Rosenberg’s Vertex Pharmaceuticals VRTX Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$91.4K	Hold	184	–	–	0.02%	357
2026 Q1	$82.2K	Hold	184	–	–	0.02%	356
2025 Q4	$83.4K	Buy	184 +11	+6%	+$4.74K	0.02%	354
2025 Q3	$67.8K	Hold	173	–	–	0.01%	384
2025 Q2	$77K	Buy	173 +21	+14%	+$9.68K	0.02%	382
2025 Q1	$73.7K	Hold	152	–	–	0.02%	361
2024 Q4	$61.2K	Hold	152	–	–	0.02%	389
2024 Q3	$70.7K	Hold	152	–	–	0.02%	372
2024 Q2	$71.6K	Hold	152	–	–	0.02%	362
2024 Q1	$63.9K	Hold	152	–	–	0.02%	390
2023 Q4	$61.8K	Hold	152	–	–	0.02%	393
2023 Q3	$52.9K	Hold	152	–	–	0.02%	407
2023 Q2	$53.5K	Buy	152 +1	+0.7%	+$337	0.02%	418
2023 Q1	$47.6K	Hold	151	–	–	0.02%	473
2022 Q4	$43.6K	Hold	151	–	–	0.01%	494
2022 Q3	$44K	Buy	151 +16	+12%	+$4.6K	0.02%	473
2022 Q2	$39K	Hold	135	–	–	0.01%	515
2022 Q1	$35K	Hold	135	–	–	0.01%	500
2021 Q4	$30K	Hold	135	–	–	0.01%	488
2021 Q3	$24K	Hold	135	–	–	0.01%	491
2021 Q2	$27K	Hold	135	–	–	0.01%	444
2021 Q1	$29K	Hold	135	–	–	0.02%	402
2020 Q4	$32K	Hold	135	–	–	0.02%	377
2020 Q3	$37K	Hold	135	–	–	0.03%	336
2020 Q2	$39K	Hold	135	–	–	0.03%	335
2020 Q1	$33K	Buy	+135	New	+$31K	0.03%	317

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

CTB

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

GIA

Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

MLL

Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Matthew Hamilton Rosenberg's VRTX Position: Q2 2026 in Review

Matthew Hamilton Rosenberg held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 184 shares worth $91.4K. The position accounts for 0.02% of the portfolio, ranked #357.

Matthew Hamilton Rosenberg first reported a position in VRTX in Q1 2020 and has held it in 26 quarters since. 296 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Matthew Hamilton Rosenberg held 184 shares of Vertex Pharmaceuticals worth $91.4K as of Q2 2026.
Matthew Hamilton Rosenberg left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
Vertex Pharmaceuticals made up 0.02% of Matthew Hamilton Rosenberg's portfolio in Q2 2026, its #357 holding.
Matthew Hamilton Rosenberg first reported a position in Vertex Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
296 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q2 2026, filed 17 Jul 2026.